Skip to main content
. 2015 Feb 1;13(1):3–8. doi: 10.1089/hs.2015.0001

Table 3.

Ebola Countermeasures-Related Funding in the FY2015 Omnibus (in $Millions)

Department/Agency Primary Purpose of Funds Appropriations Amount
HHS, Food and Drug Administration (FDA) Review, regulation, and postmarket surveillance of MCMs, and administrative activities 25
Department of Defense (DoD) $17 million for MCM procurement and $95 million for MCM RDT&E 112
NIH, National Institute of Allergy and Infectious Diseases (NIAID) Ebola countermeasures R&D 238
HHS Office of the Secretary (PHSSEF) (BARDA) To develop and purchase countermeasures, vaccines, diagnostics, and medical supplies 733
Total   1,108.00

Note. Adapted from the text of H.R. 83, the Consolidated and Further Continuing Appropriations Act, 2015.30